619 related articles for article (PubMed ID: 12885688)
1. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.
Feldman RB; Rhew DC; Wong JY; Charles RA; Goetz MB;
Arch Intern Med; 2003 Jul; 163(14):1718-26. PubMed ID: 12885688
[TBL] [Abstract][Full Text] [Related]
2. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
[TBL] [Abstract][Full Text] [Related]
3. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.
Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA;
Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
Marras TK; Nopmaneejumruslers C; Chan CK
Am J Med; 2004 Mar; 116(6):385-93. PubMed ID: 15006587
[TBL] [Abstract][Full Text] [Related]
5. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.
Frei CR; Restrepo MI; Mortensen EM; Burgess DS
Am J Med; 2006 Oct; 119(10):865-71. PubMed ID: 17000218
[TBL] [Abstract][Full Text] [Related]
6. Association between timing of intensive care unit admission and outcomes for emergency department patients with community-acquired pneumonia.
Renaud B; Santin A; Coma E; Camus N; Van Pelt D; Hayon J; Gurgui M; Roupie E; Hervé J; Fine MJ; Brun-Buisson C; Labarère J
Crit Care Med; 2009 Nov; 37(11):2867-74. PubMed ID: 19770748
[TBL] [Abstract][Full Text] [Related]
7. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia.
Mortensen EM; Restrepo M; Anzueto A; Pugh J
Am J Med; 2004 Nov; 117(10):726-31. PubMed ID: 15541321
[TBL] [Abstract][Full Text] [Related]
8. Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia.
Lee RW; Lindstrom ST
Respirology; 2007 Jan; 12(1):111-6. PubMed ID: 17207035
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae.
Kontou P; Kuti JL; Nicolau DP
Am J Emerg Med; 2009 Oct; 27(8):968-74. PubMed ID: 19857416
[TBL] [Abstract][Full Text] [Related]
10. Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study.
Griffin AT; Peyrani P; Wiemken T; Arnold F
Int J Tuberc Lung Dis; 2010 Apr; 14(4):495-9. PubMed ID: 20202309
[TBL] [Abstract][Full Text] [Related]
11. Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia?
Sánchez F; Mensa J; Martínez JA; García E; Marco F; González J; Marcos MA; Soriano A; Torres A
Clin Infect Dis; 2003 May; 36(10):1239-45. PubMed ID: 12746768
[TBL] [Abstract][Full Text] [Related]
12. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
[TBL] [Abstract][Full Text] [Related]
13. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules.
McCabe C; Kirchner C; Zhang H; Daley J; Fisman DN
Arch Intern Med; 2009 Sep; 169(16):1525-31. PubMed ID: 19752411
[TBL] [Abstract][Full Text] [Related]
14. In-hospital observation after antibiotic switch in pneumonia: a national evaluation.
Nathan RV; Rhew DC; Murray C; Bratzler DW; Houck PM; Weingarten SR
Am J Med; 2006 Jun; 119(6):512.e1-7. PubMed ID: 16750965
[TBL] [Abstract][Full Text] [Related]
15. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
Ioachimescu OC; Ioachimescu AG; Iannini PB
Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482
[TBL] [Abstract][Full Text] [Related]
16. Clinical response to ertapenem in severe community-acquired pneumonia: a retrospective series in an elderly population.
Murcia JM; González-Comeche J; Marín A; Barberán J; Granizo JJ; Aguilar L; González-Moreno J; González-Pina B; López-Dupla M; Irurzun J;
Clin Microbiol Infect; 2009 Nov; 15(11):1046-50. PubMed ID: 19548926
[TBL] [Abstract][Full Text] [Related]
17. Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia.
Phua J; See KC; Chan YH; Widjaja LS; Aung NW; Ngerng WJ; Lim TK
Thorax; 2009 Jul; 64(7):598-603. PubMed ID: 19386583
[TBL] [Abstract][Full Text] [Related]
18. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.
Houck PM; Bratzler DW; Nsa W; Ma A; Bartlett JG
Arch Intern Med; 2004 Mar; 164(6):637-44. PubMed ID: 15037492
[TBL] [Abstract][Full Text] [Related]
19. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
[TBL] [Abstract][Full Text] [Related]
20. Treatment and outcomes of community-acquired pneumonia at Canadian hospitals.
Feagan BG; Marrie TJ; Lau CY; Wheeler SL; Wong CJ; Vandervoort MK
CMAJ; 2000 May; 162(10):1415-20. PubMed ID: 10834044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]